Action 3933 THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues The United Laboratories International Holdings Limited

Actions

3933

KYG8813K1085

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:08:20 26/04/2024 		Varia. 5j. Varia. 1 janv.
9,48 HKD -2,97% Graphique intraday de The United Laboratories International Holdings Limited -1,15% +35,24%
27/03 The United Laboratories International Holdings Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
27/03 Les bénéfices de 2023 de United Laboratories International augmentent grâce à la hausse des revenus MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
The United Laboratories International's 2023 Profit Rises on Higher Revenue
The United Laboratories International Holdings Limited Recommends Payment of Final Dividend for the Year Ended 31 December 2023
The United Laboratories International Holdings Limited Recommends Payment of Special Dividend for the Year Ended 31 December 2023
The United Laboratories International Forecasts Profit Surge in 2023
The United Laboratories International Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
United Laboratories Postpones EGM Due to Bad Weather
United Laboratories Subsidiary Gets US FDA Nod for Injectable for Diabetes; Shares Rise 8%
The United Laboratories International Holdings Limited Announces FDA Approval of IND for UBT251 Injection
The United Laboratories International Holdings Limited Announces Interim Dividend for Six Months Ended 30 June 2023, Payable on 11 October 2023
United Laboratories Controlling Shareholder to Sell 64 Million Shares
United Laboratories International Unit Gets Regulatory Nod to Conduct Trial on TUL01101 Tablets
Chinese Regulator Allows Clinical Trial of United Laboratories' Fatty-Liver Drug
The United Laboratories International Holdings Limited Announces Application for the Clinical Trial of Class 1 Innovative New Drug UBT251 Injection
United Laboratories International Says Two Products Pass Consistency Evaluation
China Greenlights United Laboratories' Clinical Trial for Obesity Injection; Shares Rise 4%
The United Laboratories International Holdings Limited Announces Approval for Clinical Trial of Ubt251 Injection on Indication of Overweight or Obesity
The United Laboratories International Holdings Limited Announces Ordinary Interim (Semi-Annual) Dividend for Six Months Ended 30 June 2023
United Laboratories' H1 Profit Doubles; Shares Fall 4%
The United Laboratories International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 3933
  4. Actualités The United Laboratories International Holdings Limited
  5. Autres langues